Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.92 EUR | +1.37% | +5.71% | -32.27% |
May. 07 | Talea Group launches its private label branded Farmaè | AN |
Apr. 23 | Talea closes first quarter with revenues up | AN |
Valuation
Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 221.1 | 75.31 | 39.93 | - | - |
Enterprise Value (EV) 1 | 221.1 | 96.61 | 74.08 | 72.23 | 67.88 |
P/E ratio | - | - | -35.5 x | 12.4 x | 6.81 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.68 x | 0.65 x | 0.24 x | 0.19 x | 0.17 x |
EV / Revenue | 2.68 x | 0.83 x | 0.44 x | 0.35 x | 0.29 x |
EV / EBITDA | - | 38.6 x | 19.5 x | 7.73 x | 5.14 x |
EV / FCF | - | - | 9.5 x | 53.5 x | 17.6 x |
FCF Yield | - | - | 10.5% | 1.87% | 5.67% |
Price to Book | - | - | 1.35 x | 1.22 x | 1.03 x |
Nbr of stocks (in thousands) | 6,846 | 6,846 | 6,838 | - | - |
Reference price 2 | 32.30 | 11.00 | 5.840 | 5.840 | 5.840 |
Announcement Date | 4/14/22 | 3/28/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 82.48 | 116.3 | 169.2 | 206.4 | 232.8 |
EBITDA 1 | - | 2.5 | 3.8 | 9.35 | 13.2 |
EBIT 1 | - | -0.0382 | 0.4 | 5.6 | 9.25 |
Operating Margin | - | -0.03% | 0.24% | 2.71% | 3.97% |
Earnings before Tax (EBT) 1 | - | -0.8418 | -0.95 | 4.5 | 8.25 |
Net income 1 | -0.0897 | -0.9076 | -1.15 | 3.25 | 5.85 |
Net margin | -0.11% | -0.78% | -0.68% | 1.57% | 2.51% |
EPS 2 | - | - | -0.1645 | 0.4705 | 0.8570 |
Free Cash Flow 1 | - | - | 7.8 | 1.35 | 3.85 |
FCF margin | - | - | 4.61% | 0.65% | 1.65% |
FCF Conversion (EBITDA) | - | - | 205.26% | 14.44% | 29.17% |
FCF Conversion (Net income) | - | - | - | 41.54% | 65.81% |
Dividend per Share | - | - | - | - | - |
Announcement Date | 4/14/22 | 3/28/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 S1 |
---|---|
Net sales 1 | 72.93 |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income | - |
Net margin | - |
EPS | - |
Dividend per Share | - |
Announcement Date | 9/26/23 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | 21.3 | 34.2 | 32.3 | 28 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 8.52 x | 8.987 x | 3.455 x | 2.117 x |
Free Cash Flow 1 | - | - | 7.8 | 1.35 | 3.85 |
ROE (net income / shareholders' equity) | - | - | -3.75% | 9.95% | 15.7% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share 2 | - | - | 4.340 | 4.810 | 5.660 |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | 5.1 | 5.75 | 6 |
Capex / Sales | - | - | 3.02% | 2.79% | 2.58% |
Announcement Date | 4/14/22 | 3/28/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.27% | 43.04M | |
+2.40% | 193B | |
-5.92% | 191B | |
-1.09% | 99.27B | |
+38.58% | 91.5B | |
+7.45% | 85.61B | |
+14.14% | 53.77B | |
+14.79% | 25.36B | |
+26.53% | 11.07B | |
-11.88% | 8.49B |
- Stock Market
- Equities
- FAR Stock
- Financials Talea Group S.p.A.